Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer with High-Risk Features Following Radical Prostatectomy | Synapse
March 3, 2026
Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer with High-Risk Features Following Radical Prostatectomy
Key Points
Prostate bed stereotactic body radiation therapy improves outcomes in high-risk prostate cancer patients, enhancing recovery.
The primary efficacy assessment shows a significant 50% reduction in cancer recurrence after treatment.
Phase II clinical trial explores the effectiveness of targeted radiation therapy in post-surgical patients.
Support for innovative therapies highlights the need for further studies in larger populations to confirm these findings.